Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA known ✓ | P10253 | 2/20 | 0.35 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.33 |
| ▸ | MAOB known ✓ | P27338 | 1/20 | 0.30 |
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.30 |
| ▸ | PTGS2 known ✓ | P35354 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.34 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.32 |
| ▸ | NEK2 | P51955 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1074845 | 1.00 | TDP1 (0.39) | TDP1CYP3A4ALDH1A1TP53MAPK1 | |
| Hydrochloric Acid SCHEMBL9474755 | 0.98 | CYP3A4 (0.38) | TDP1CYP3A4ALDH1A1TP53MAPK1 | |
| SCHEMBL27687136 | 0.98 | CYP3A4 (0.40) | TDP1CYP3A4ALDH1A1TP53MAPK1 | |
| SCHEMBL21548 | 0.98 | CYP3A4 (0.40) | TDP1CYP3A4ALDH1A1TP53MAPK1 | |
| Benzidine SCHEMBL4523874 | 0.96 | CYP3A4 (0.41) | TDP1CYP3A4ALDH1A1TP53MAPK1 | |
| SCHEMBL3220425 | 0.96 | CYP3A4 (0.39) | TDP1CYP3A4ALDH1A1TP53MAPK1 | |
| SCHEMBL28406929 | 0.95 | CYP3A4 (0.38) | TDP1CYP3A4ALDH1A1TP53MAPK1 | |
| Methyl Alcohol SCHEMBL27789369 | 0.95 | CYP3A4 (0.38) | TDP1CYP3A4ALDH1A1TP53MAPK1 | |
| Hydrogen Peroxide SCHEMBL623863 | 0.95 | RXRA (0.38) | TDP1CYP3A4ALDH1A1TP53MAPK1 | |
| Alcohol SCHEMBL27849531 | 0.91 | RXRA (0.36) | TDP1CYP3A4ALDH1A1TP53MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120202236-A1 | COMPOSITE ANIMAL LITTER MATERIAL AND METHODS | 7905122 CANADA INC. (CA) | 2012-08-09 | — | — | US | claimed |
| EP-2433127-A1 | COMPOSITE ANIMAL LITTER MATERIAL AND METHODS | 7905122 Canada Inc. (CA) | 2012-03-28 | — | — | EP | claimed |
| WO-2010133001-A1 | COMPOSITE ANIMAL LITTER MATERIAL AND METHODS | LES PROCEDES SERVI-SAND CANADA INC (CA) | 2010-11-25 | — | — | WO | claimed |
| EP-1274999-B1 | METHOD AND TEST STRIP OF DETECTING OXIDIZING ADULTERANT IN URINE | BRANAN MEDICAL CORP (US) | 2010-11-17 | — | — | EP | claimed |
| EP-1274999-A4 | METHOD AND TEST STRIP OF DETECTING OXIDIZING ADULTERANT IN URINE | BRANAN MEDICAL CORP (US) | 2006-05-24 | — | — | EP | claimed |
| EP-1274999-A1 | METHOD AND TEST STRIP OF DETECTING OXIDIZING ADULTERANT IN URINE | Branan Medical Corp. (US) | 2003-01-15 | — | — | EP | claimed |
| WO-2001075444-A1 | METHOD AND TEST STRIP OF DETECTING OXIDIZING ADULTERANT IN URINE | BRANAN MEDICAL CORP. (US) | 2001-10-11 | — | — | WO | claimed |
| US-5902727-A | SIMPLE AND EFFICIENT ANALYSIS BY BINDING ENZYME LINKED PROBE TO TARGET, ADDING SUBSTRATE(S), DETECTING INSOLUBLE AND SOLUBLE PRODUCTS | WASHINGTON UNIVERSITY (US) | 1999-05-11 | — | — | US | claimed |
| CN-1056304-A | 3,5,3 ', 5 '-preparation method of tetramethyl benzidine and hydrochloride thereof | MEDICINAL COLLEGE CHINA MEDICA (CN) | 1991-11-20 | — | — | CN | claimed |
| EP-0196743-A2 | Stable chemical compositions containing chromogenic materials and peroxides, and method for obtaining them | SAVYON DIAGNOSTICS LTD. (IL) | 1986-10-08 | — | — | EP | claimed |
| CN-118731353-B | Plasma autoantibody marker for identifying lung adenocarcinoma and benign lung diseases and application thereof | 郑州大学 | 2026-02-27 | — | — | CN | disclosed |
| EP-4532543-A1 | ANTI-BCMA ANTIBODIES | Sanofi (FR) | 2025-04-09 | — | — | EP | disclosed |
| CN-119595913-A | Application of anti-FUCA 2 autoantibody in preparation of lung adenocarcinoma auxiliary diagnosis product | 郑州大学 | 2025-03-11 | — | — | CN | disclosed |
| CN-119438603-A | Application of anti-ATP 6V0D1 autoantibody in lung adenocarcinoma auxiliary diagnosis | 郑州大学 | 2025-02-14 | — | — | CN | disclosed |
| CN-119001101-A | Use of anti-GSDMD autoantibodies in the preparation of products for diagnosing lung adenocarcinoma | 郑州大学 | 2024-11-22 | — | — | CN | disclosed |
| EP-0071934-B1 | METHOD FOR PREPARING A COLOR STABLE CHROMOGENIC ANALYTICAL ELEMENT | MILES LABORATORIES, INC. (US) | 1986-06-11 | — | — | EP | disclosed |
| US-4525452-A | Enzyme immunoassay with step of immersing sample in deionized water | BTC DIAGNOSTICS LIMITED PARTNERSHIP (US) | 1985-06-25 | — | — | US | disclosed |
| US-4503143-A | Enzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen | BTC DIAGNOSTICS LIMITED PARTNERSHIP (US) | 1985-03-05 | — | — | US | disclosed |
| EP-0071934-A1 | Method for preparing a color stable chromogenic analytical element | MILES LABORATORIES, INC. (US) | 1983-02-16 | — | — | EP | disclosed |
| US-4361648-A | POLYMERIC MORDANT, TETRAALKYLBENZIDINE HYDROCHLORIDE, ENZYME, PEROXIDATIVELY ACTIVE MATERIAL | MILES LABORATORIES, INC. (US) | 1982-11-30 | — | — | US | disclosed |